Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -294,912 | -138,935 | -746,354 | -598,421 | -402,850 |
| Depreciation Amortization | 14,328 | 504 | 3,648 | 1,937 | 1,521 |
| Accounts receivable | 2,584 | 3,773 | -10,103 | -2,618 | -719 |
| Accounts payable and accrued liabilities | 2,591 | -6,371 | 10,487 | -3,213 | -3,296 |
| Other Working Capital | 17,126 | -1,823 | -93,522 | -52,741 | 5,747 |
| Other Operating Activity | 39,699 | 31,292 | 272,718 | 204,429 | 117,595 |
| Operating Cash Flow | $-218,584 | $-111,560 | $-563,126 | $-450,627 | $-282,002 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -477 | -86 | -1,103 | -1,084 | -732 |
| Purchase Of Investment | -331,863 | -331,863 | -171,281 | -171,280 | -171,281 |
| Sale Of Investment | 143,320 | 60,000 | 420,000 | 335,000 | 155,000 |
| Investing Cash Flow | $-189,020 | $-271,949 | $247,616 | $162,636 | $-17,013 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 391,421 | 384,120 | 398,024 | 13,829 | 11,348 |
| Other Financing Activity | -19,452 | -7,416 | -5,788 | -5,551 | -5,190 |
| Financing Cash Flow | $371,969 | $376,704 | $392,236 | $8,278 | $6,158 |
| Exchange Rate Effect | -365 | 64 | -2,016 | -2,024 | -1,852 |
| Beginning Cash Position | 641,755 | 641,755 | 567,045 | 567,045 | 567,045 |
| End Cash Position | 605,755 | 635,014 | 641,755 | 285,308 | 272,336 |
| Net Cash Flow | $-36,000 | $-6,741 | $74,710 | $-281,737 | $-294,709 |
| Free Cash Flow | |||||
| Operating Cash Flow | -218,584 | -111,560 | -563,126 | -450,627 | -282,002 |
| Capital Expenditure | -477 | -86 | -1,103 | -1,084 | -732 |
| Free Cash Flow | -219,061 | -111,646 | -564,229 | -451,711 | -282,734 |